(R)-Crizotinib

(R)-Crizotinib


(R)-Crizotinib is a dual inhibitor of c-Met and anaplastic lymphoma kinase (ALK) with IC50 values of 8 nM and 20 nM, respectively, in a cell-based assay. It selectively inhibits c-Met and ALK over several other tyrosine kinases, including Ron, Tie2, Abl, LCK, and VEGFR2. (R)-Crizotinib effectively suppresses the proliferation of cancer cell lines with MET amplifications and induces apoptosis in MET-amplified lung cancer cells. It also acts as a ROS1 inhibitor. Reagent grade, for research use only.

Molecular structure of the compound BP-43636
    • Unit
    • Price
    • Qty
    • 1 G
    • $120.00
    • 5 G
    • $280.00
    • 10 G
    • $480.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire